Table of Content

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16

2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porter’s Fiver Forces Analysis 39

3 Segmentation of North America Market by Product 43
3.1 Market Overview by Product 43
3.2 Consumables 45
3.3 Analyzers/Instruments 46

4 Segmentation of North America Market by Prescription 47
4.1 Market Overview by Prescription 47
4.2 Professional Diagnostics 49
4.3 OTC Based Testing 50

5 Segmentation of North America Market by Platform 51
5.1 Market Overview by Platform 51
5.2 Immunoassays 53
5.2.1 Lateral Flow Assays 55
5.2.2 Serological Assays 56
5.2.3 Other Immunoassays 57
5.3 Molecular Detection 58
5.3.1 Polymerase Chain Reaction (PCR) 59
5.3.2 Other Molecular Detection Tests 60
5.4 Other Platforms 61

6 Segmentation of North America Market by Application 62
6.1 Market Overview by Application 62
6.2 Blood Glucose Testing 64
6.3 Cardiometabolic Testing 65
6.4 Infectious Disease Testing 66
6.4.1 COVID-19 Testing 68
6.4.2 Healthcare-associated Infections (HAI) Testing 69
6.4.3 Hepatitis Testing 70
6.4.4 Tropical Diseases Testing 71
6.4.5 HIV Testing 72
6.4.6 Influenza Testing 73
6.4.7 Sexually Transmitted Diseases (STD) Testing 74
6.4.8 Other Infectious Diseases Testing 75
6.5 Blood Coagulation Testing 76
6.6 Hematology Testing 77
6.7 Cancer Testing 78
6.8 Drug Abuse Testing 79
6.9 Pregnancy & Fertility Testing 80
6.10 Other Applications 81

7 Segmentation of North America Market by End User 82
7.1 Market Overview by End User 82
7.2 Hospitals & Clinics 84
7.3 Laboratories 85
7.4 Individuals/Homecare 86
7.5 Other End Users 87

8 North America Market 2021-2031 by Country 88
8.1 Overview of North America Market 88
8.2 U.S. 91
8.3 Canada 94
8.4 Mexico 96

9 Competitive Landscape 98
9.1 Overview of Key Vendors 98
9.2 New Product Launch, Partnership, Investment, and M&A 103
9.3 Company Profiles 105
Abbott Diagnostics 105
ACON Laboratories 107
Becton Dickinson and Co. 108
BioM?rieux S.A. 109
Bio-Rad Laboratories, Inc. 110
Chembio Diagnostic Systems 111
Danaher Corp. 112
F. Hoffmann La Roche Ltd. 113
GlySens Inc. 114
Meridian Bioscience Inc. 115
OraSure Technologies Inc. 116
Siemens Healthineers AG 117
Thermo Fisher Scientific Inc. 118
Trinity Biotech Plc 119
RELATED REPORTS 120



List of Figures

List of Figures:

Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. North America Rapid Diagnostics Market, 2021-2031, $ mn 19
Figure 5. Impact of COVID-19 on Business 24
Figure 6. Primary Drivers and Impact Factors of North America Rapid Diagnostics Market 26
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million 29
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 30
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 30
Figure 10. Primary Restraints and Impact Factors of North America Rapid Diagnostics Market 32
Figure 11. Investment Opportunity Analysis 36
Figure 12. Porter’s Fiver Forces Analysis of North America Rapid Diagnostics Market 39
Figure 13. Breakdown of North America Rapid Diagnostics Market by Product, 2021-2031, % of Revenue 44
Figure 14. North America Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%) 44
Figure 15. North America Rapid Diagnostics Market by Product: Consumables, 2021-2031, $ mn 45
Figure 16. North America Rapid Diagnostics Market by Product: Analyzers/Instruments, 2021-2031, $ mn 46
Figure 17. Breakdown of North America Rapid Diagnostics Market by Prescription, 2021-2031, % of Sales Revenue 48
Figure 18. North America Addressable Market Cap in 2022-2031 by Prescription, Value ($ mn) and Share (%) 48
Figure 19. North America Rapid Diagnostics Market by Prescription: Professional Diagnostics, 2021-2031, $ mn 49
Figure 20. North America Rapid Diagnostics Market by Prescription: OTC Based Testing, 2021-2031, $ mn 50
Figure 21. Breakdown of North America Rapid Diagnostics Market by Platform, 2021-2031, % of Sales Revenue 52
Figure 22. North America Addressable Market Cap in 2022-2031 by Platform, Value ($ mn) and Share (%) 52
Figure 23. North America Rapid Diagnostics Market by Platform: Immunoassays, 2021-2031, $ mn 53
Figure 24. North America Rapid Diagnostics Market by Immunoassays: Lateral Flow Assays, 2021-2031, $ mn 55
Figure 25. North America Rapid Diagnostics Market by Immunoassays: Serological Assays, 2021-2031, $ mn 56
Figure 26. North America Rapid Diagnostics Market by Immunoassays: Other Immunoassays, 2021-2031, $ mn 57
Figure 27. North America Rapid Diagnostics Market by Platform: Molecular Detection, 2021-2031, $ mn 58
Figure 28. North America Rapid Diagnostics Market by Molecular Detection: Polymerase Chain Reaction (PCR), 2021-2031, $ mn 59
Figure 29. North America Rapid Diagnostics Market by Molecular Detection: Other Molecular Detection Tests, 2021-2031, $ mn 60
Figure 30. North America Rapid Diagnostics Market by Platform: Other Platforms, 2021-2031, $ mn 61
Figure 31. Breakdown of North America Rapid Diagnostics Market by Application, 2021-2031, % of Revenue 63
Figure 32. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 63
Figure 33. North America Rapid Diagnostics Market by Application: Blood Glucose Testing, 2021-2031, $ mn 64
Figure 34. North America Rapid Diagnostics Market by Application: Cardiometabolic Testing, 2021-2031, $ mn 65
Figure 35. North America Rapid Diagnostics Market by Application: Infectious Disease Testing, 2021-2031, $ mn 66
Figure 36. North America Rapid Diagnostics Market by Infectious Disease Testing: COVID-19 Testing, 2021-2031, $ mn 68
Figure 37. North America Rapid Diagnostics Market by Infectious Disease Testing: Healthcare-associated Infections (HAI) Testing, 2021-2031, $ mn 69
Figure 38. North America Rapid Diagnostics Market by Infectious Disease Testing: Hepatitis Testing, 2021-2031, $ mn 70
Figure 39. North America Rapid Diagnostics Market by Infectious Disease Testing: Tropical Diseases Testing, 2021-2031, $ mn 71
Figure 40. North America Rapid Diagnostics Market by Infectious Disease Testing: HIV Testing, 2021-2031, $ mn 72
Figure 41. North America Rapid Diagnostics Market by Infectious Disease Testing: Influenza Testing, 2021-2031, $ mn 73
Figure 42. North America Rapid Diagnostics Market by Infectious Disease Testing: Sexually Transmitted Diseases (STD) Testing, 2021-2031, $ mn 74
Figure 43. North America Rapid Diagnostics Market by Infectious Disease Testing: Other Infectious Diseases Testing, 2021-2031, $ mn 75
Figure 44. North America Rapid Diagnostics Market by Application: Blood Coagulation Testing, 2021-2031, $ mn 76
Figure 45. North America Rapid Diagnostics Market by Application: Hematology Testing, 2021-2031, $ mn 77
Figure 46. North America Rapid Diagnostics Market by Application: Cancer Testing, 2021-2031, $ mn 78
Figure 47. North America Rapid Diagnostics Market by Application: Drug Abuse Testing, 2021-2031, $ mn 79
Figure 48. North America Rapid Diagnostics Market by Application: Pregnancy & Fertility Testing, 2021-2031, $ mn 80
Figure 49. North America Rapid Diagnostics Market by Application: Other Applications, 2021-2031, $ mn 81
Figure 50. Breakdown of North America Rapid Diagnostics Market by End User, 2021-2031, % of Revenue 83
Figure 51. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 83
Figure 52. North America Rapid Diagnostics Market by End User: Hospitals & Clinics, 2021-2031, $ mn 84
Figure 53. North America Rapid Diagnostics Market by End User: Laboratories, 2021-2031, $ mn 85
Figure 54. North America Rapid Diagnostics Market by End User: Individuals/Homecare, 2021-2031, $ mn 86
Figure 55. North America Rapid Diagnostics Market by End User: Other End Users, 2021-2031, $ mn 87
Figure 56. Breakdown of North America Rapid Diagnostics Market by Country, 2021 and 2031, % of Revenue 89
Figure 57. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 90
Figure 58. U.S. Rapid Diagnostics Market, 2021-2031, $ mn 92
Figure 59. Canada Rapid Diagnostics Market, 2021-2031, $ mn 94
Figure 60. Rapid Diagnostics Market in Mexico, 2021-2031, $ mn 96
Figure 61. Growth Stage of North America Rapid Diagnostics Industry over the Forecast Period 98

List of Tables

List of Tables:

Table 1. Snapshot of North America Rapid Diagnostics Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Economic Outlook, 2021-2023 22
Table 4. World Health Spending by Region, $ bn, 2013-2020 31
Table 5. Main Product Trends and Market Opportunities in North America Rapid Diagnostics Market 35
Table 6. North America Rapid Diagnostics Market by Product, 2021-2031, $ mn 43
Table 7. North America Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 47
Table 8. North America Rapid Diagnostics Market by Platform, 2021-2031, $ mn 51
Table 9. North America Rapid Diagnostics Market: Immunoassays by Type, 2021-2031, $ mn 54
Table 10. North America Rapid Diagnostics Market: Molecular Detection by Type, 2021-2031, $ mn 58
Table 11. North America Rapid Diagnostics Market by Application, 2021-2031, $ mn 62
Table 12. North America Rapid Diagnostics Market: Infectious Disease Testing by Type, 2021-2031, $ mn 67
Table 13. North America Rapid Diagnostics Market by End User, 2021-2031, $ mn 82
Table 14. North America Rapid Diagnostics Market by Country, 2021-2031, $ mn 89
Table 15. U.S. Rapid Diagnostics Market by Product, 2021-2031, $ mn 93
Table 16. U.S. Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 93
Table 17. U.S. Rapid Diagnostics Market by Application, 2021-2031, $ mn 93
Table 18. Canada Rapid Diagnostics Market by Product, 2021-2031, $ mn 95
Table 19. Canada Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 95
Table 20. Canada Rapid Diagnostics Market by Application, 2021-2031, $ mn 95
Table 21. Mexico Rapid Diagnostics Market by Product, 2021-2031, $ mn 97
Table 22. Mexico Rapid Diagnostics Market by Prescription, 2021-2031, $ mn 97
Table 23. Mexico Rapid Diagnostics Market by Application, 2021-2031, $ mn 97
Table 24. Rapid Diagnostic Analyzers by Vendor 100
Table 25. Recent Product Launches, 2018-2021 104
Table 26. Abbott Diagnostics: Company Snapshot 105
Table 27. Abbott Diagnostics: Business Segmentation 106
Table 28. Abbott Diagnostics: Product Portfolio 106